Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Olfactory Outcomes in CRSwNP
NCT04869436Phase 4Completed
- Start
- Jul 2021
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP), Olfactory disorder. Started Jul 2021; status: completed.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)Olfactory disorder
Beyond the preview
Go deeper on NCT04869436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04869436.